Dashboard
Manage Tickers

ATRA


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

crude-oil-down-1-dollar-tree-shares-tumble-after-downbeat-earnings
Crude Oil Down 1%; Dollar Tree Shares Tumb...
09/04/2024 17:32:14

atara-biotherapeutics-atra-stock-is-up-20-whats-going-on
Atara Biotherapeutics (ATRA) Stock Is Up 2...
09/04/2024 16:02:44

Atara Biotherapeutics shares are trading higher by 20% Wednesday morning. The company announced a $36 million registered direct...

why-gitlab-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket
Why GitLab Shares Are Trading Higher By Ar...
09/04/2024 10:39:51

atara-biotherapeutics-announces-36m-registered-direct-offering-of-758900-shares-at-825share
Atara Biotherapeutics Announces $36M Regis...
09/03/2024 20:17:22

hc-wainwright--co-reiterates-neutral-on-atara-biotherapeutics
HC Wainwright & Co. Reiterates Neutral on ...
08/21/2024 12:19:22

HC Wainwright & Co. analyst Robert Burns reiterates Atara Biotherapeutics (NASDAQ:ATRA) with a Neutral.

mizuho-upgrades-atara-biotherapeutics-to-outperform-lowers-price-target-to-18
Mizuho Upgrades Atara Biotherapeutics to O...
08/16/2024 17:42:34

Mizuho analyst Salim Syed upgrades Atara Biotherapeutics (NASDAQ:ATRA) from Neutral to Outperform and lowers the price targe...

canaccord-genuity-maintains-buy-on-atara-biotherapeutics-maintains-13-price-target
Canaccord Genuity Maintains Buy on Atara B...
08/13/2024 16:19:54

Canaccord Genuity analyst John Newman maintains Atara Biotherapeutics (NASDAQ:ATRA) with a Buy and maintains $13 price target.

atara-biotherapeutics-expects-cash-runway-into-2027-enabling-key-pipeline-readouts
Atara Biotherapeutics Expects Cash Runway ...
08/12/2024 21:17:23

It plans to initiate ATA3219 Systemic Lupus Erythematosus trial in the fourth quarter, including the cohort without lymphodeple...

atara-biotherapeutics-q2-2024-gaap-eps-310-misses-156-estimate-sales-2864m-miss-3999m-estimate
Atara Biotherapeutics Q2 2024 GAAP EPS $(3...
08/12/2024 21:15:26

Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(3.10) per share which missed the analyst consensus estimate ...

goldman-sachs-maintains-sell-on-atara-biotherapeutics-lowers-price-target-to-11
Goldman Sachs Maintains Sell on Atara Biot...
07/17/2024 15:58:12

Goldman Sachs analyst Tommie Reerink maintains Atara Biotherapeutics (NASDAQ:ATRA) with a Sell and lowers the price target f...

atara-biotherapeutics-receives-fda-acceptance-and-priority-review-of-biologics-license-application-for-tabelecleucel-for-treatment-of-epstein-barr-virus-positive-post-transplant-lymphoproliferative-disease
Atara Biotherapeutics Receives FDA Accepta...
07/17/2024 13:05:52

Prescription Drug User Fee Act (PDUFA) Target Action Date of January 15, 2025If Approved, Tab-cel Would Be First Approved Thera...

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
06/18/2024 23:50:04

why-ovid-therapeutics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Ovid Therapeutics Shares Are Trading L...
06/17/2024 17:21:47

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/17/2024 16:31:43

atara-biotherapeutics-to-conduct-1-for-25-reverse-stock-split-effective-jun-20
Atara Biotherapeutics To Conduct 1-for-25 ...
06/17/2024 12:06:18

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/31/2024 20:32:51

atara-biotherapeutics-to-present-preclinical-data-on-ata3219-an-allogeneic-cd19-targeted-car-t-therapy-for-the-treatment-of-b-cell-driven-autoimmune-diseases-at-the-isct-2024-annual-meeting
Atara Biotherapeutics To Present Preclinic...
05/29/2024 20:02:12

ATA3219 Demonstrates Complete CD19-Specific B-Cell Depletion Against Systemic Lupus Erythematosus and Multiple Sclerosis Patien...

hc-wainwright--co-reiterates-neutral-on-atara-biotherapeutics
HC Wainwright & Co. Reiterates Neutral on ...
05/22/2024 11:07:58

HC Wainwright & Co. analyst Robert Burns reiterates Atara Biotherapeutics (NASDAQ:ATRA) with a Neutral.

atara-biotherapeutics-submits-tabelecleucel-bla-for-treatment-of-epstein-barr-virus-positive-post-transplant-lymphoproliferative-disease-with-us-fda-acceptance-of-bla-will-trigger-20m-milestone-payment-from-pierre-fabre-laboratories-with-potential-for-additional-60m-milestone-upon-fda-approval
Atara Biotherapeutics Submits Tabelecleuce...
05/20/2024 13:27:03

First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug AdministrationIf Approved, Tab-cel Would be First Approved...

atara-biotherapeutics-q1-2024-gaap-eps-023-beats-025-estimate
Atara Biotherapeutics Q1 2024 GAAP EPS $(0...
05/09/2024 20:46:53

Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION